NeoCore Technology Co., Ltd. (TPEX:4131)
39.70
-0.35 (-0.87%)
Jan 22, 2026, 10:16 AM CST
NeoCore Technology Revenue
NeoCore Technology had revenue of 55.20M TWD in the quarter ending September 30, 2025, with 234.95% growth. This brings the company's revenue in the last twelve months to 190.10M, up 178.43% year-over-year. In the year 2024, NeoCore Technology had annual revenue of 61.55M, down -4.92%.
Revenue (ttm)
190.10M
Revenue Growth
+178.43%
P/S Ratio
8.32
Revenue / Employee
4.32M
Employees
44
Market Cap
1.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 61.55M | -3.18M | -4.92% |
| Dec 31, 2023 | 64.73M | -24.24M | -27.24% |
| Dec 31, 2022 | 88.97M | 42.00K | 0.05% |
| Dec 31, 2021 | 88.93M | -4.42M | -4.73% |
| Dec 31, 2020 | 93.35M | -11.14M | -10.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chunghwa Chemical Synthesis & Biotech | 977.79M |
| Genomics BioSci & Tech. | 607.89M |
| Meribank Biotech | 486.52M |
| GenMont Biotech Incorporation | 391.48M |
| Abnova (Taiwan) | 355.40M |
| GeneReach Biotechnology | 215.32M |
| Lukas Biomedical | 180.32M |
| Enimmune corporation | 42.23M |